264 related articles for article (PubMed ID: 16959710)
1. Malignant mesothelioma masquerading as a multinodular bronchioloalveolar cell adenocarcinoma with widespread pulmonary nodules.
Felner KJ; Wieczorek R; Kline M; Smith RL; Sidhu GS
Int J Surg Pathol; 2006 Jul; 14(3):229-33. PubMed ID: 16959710
[TBL] [Abstract][Full Text] [Related]
2. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
3. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
4. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
5. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
[TBL] [Abstract][Full Text] [Related]
6. [Pseudomesotheliomatous carcinoma of the lung].
Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
[TBL] [Abstract][Full Text] [Related]
7. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
9. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
Deniz H; Kibar Y; Güldür ME; Bakir K
Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Frey AB; Wali A; Pass H; Lonardo F
Histopathology; 2007 May; 50(6):720-6. PubMed ID: 17493236
[TBL] [Abstract][Full Text] [Related]
11. [A case of bronchiolar cancer simulating pleural mesothelioma].
Kubiak Z; Pruszczyński M
Wiad Lek; 1969 Feb; 22(3):257-60. PubMed ID: 4305266
[No Abstract] [Full Text] [Related]
12. [Large-cell carcinoma presenting as diffuse thickening of the pleura and resembling malignant mesothelioma].
Nakamura H; Ikeda I; Nakahama H; Kitada O; Sugita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):451-4. PubMed ID: 9212673
[TBL] [Abstract][Full Text] [Related]
13. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients.
Kayser K; Böhm G; Blum S; Beyer M; Zink S; André S; Gabius HJ
J Pathol; 2001 Feb; 193(2):175-80. PubMed ID: 11180163
[TBL] [Abstract][Full Text] [Related]
14. D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen.
Naito Y; Ishii G; Kawai O; Hasebe T; Nishiwaki Y; Nagai K; Ochiai A
Pathol Int; 2007 Sep; 57(9):618-21. PubMed ID: 17685935
[TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
Kobashi Y; Matsushima T; Irei T
Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary blastoma within bronchioloalveolar cell carcinoma.
Harada T; Sukoh N; Hakuma N; Kamimura A; Ito K; Okamoto K
Respirology; 2006 May; 11(3):339-42. PubMed ID: 16635096
[TBL] [Abstract][Full Text] [Related]
18. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
19. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.
Dewar A; Valente M; Ring NP; Corrin B
J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733
[TBL] [Abstract][Full Text] [Related]
20. Exclusive intrapulmonary lepidic growth of a malignant pleural mesothelioma presenting with pneumothorax and involving the peritoneum.
Rossi G; Cavazza A; Turrini E; Costantini M; Casali C; Morandi U; Dallari R
Int J Surg Pathol; 2006 Jul; 14(3):234-7. PubMed ID: 16959711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]